Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis

Strahlentherapie und Onkologie

Volumn 185, Issue 12, 2009, Pages 782-788

  Sugahara, Shinji ^a,b   Nakayama, Hidetsugu ^a   Fukuda, Kuniaki ^a   Mizumoto, Masashi ^a   Tokita, Mari ^c   Abei, Masato ^a   Shoda, Junichi ^a   Matsuzaki, Yasushi ^d   Thono, Eriko ^a   Tsuboi, Koji ^a   Tokuuye, Koichi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c BROWN UNIVERSITY   (United States)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Portal vein tumor thrombus; Proton beam therapy; Radiation therapy

Indexed keywords

ADULT; AGED; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MALE; PORTAL VEIN THROMBOSIS; PROGRESSION FREE SURVIVAL; PROTON THERAPY; RADIATION DOSE; TREATMENT OUTCOME; TUMOR THROMBUS; TUMOR VOLUME; ADJUVANT THERAPY; ARTICLE; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DISEASE FREE SURVIVAL; LIVER TUMOR; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PORTAL VEIN; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION INJURY; RETROSPECTIVE STUDY; TUMOR EMBOLISM;

PROTON;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PORTAL VEIN; PROGNOSIS; PROTONS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 73449100165     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-009-2020-x     Document Type: Conference Paper

References (45)

1. D.J. Allison H. Jordan O. Hennessy 1985 Therapeutic embolisation of the hepatic artery: a review of 75 procedures Lancet 1 595 599 10.1016/S0140- 6736(85)92142-7 1:STN:280:DyaL2M7js1KnsA%3D%3D 2857944
2. E. Ando M. Tanaka F. Yamashita, et al. 2002 Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombus. Analysis of 48 cases Cancer 95 588 595 10.1002/cncr.10694 12209752 (Pubitemid 34810185)
3. S. Arii Y. Yamaoka S. Futagawa, et al. 2000 Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan Hepatology 32 1224 1229 10.1053/jhep.2000.20456 1:STN:280:DC%2BD3M%2FntFegsQ%3D%3D 11093728
4. G.E. Bekkering A.W. Rutjes V.V. Vlassov, et al. 2009 The effectiveness and safety of proton radiation therapy for indications of the eye. A systematic review Strahlenther Onkol 185 211 221 10.1007/s00066-009-1900-4 19370423
5. F.X. Bosch J. Ribes J. Borras 1999 Epidemiology of primary liver cancer Semin Liver Dis 19 271 285 10.1055/s-2007-1007117 1:STN:280:DyaK1Mvks1Gktw%3D%3D 10518307
6. G.C. Cook 1985 Hepatocellular carcinoma: one of the world's most common malignancies Q J Med 57 705 708 1:STN:280:DyaL28%2FpsFSntQ%3D%3D 3001812
7. D.R. Cox 1972 Regression models and life-tables J R Stat Soc B 34 187 220
8. J.D. Cox J. Stetz T.F. Pajak 1995 Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radial Oncol Biol Phys 31 1341 1346 1:STN:280:DyaK2M3ivFCrsA%3D%3D
9. M. Del Gaudio G.L. Grazi A. Principe, et al. 2004 Influence of prognostic factors on the outcome of liver transplantation for hepatocellular carcinoma on cirrhosis: a univariate and multivariate analysis Hepatogastroenterology 51 510 514 15086193
10. R. Doci P. Bignami F. Bozzetti, et al. 1988 Intrahepatic chemotherapy for unresectable hepatocellular carcinoma Cancer 61 1983 1987 10.1002/1097- 0142(19880515)61:10<1983::AID-CNCR2820611009>3.0.CO;2-V 1:STN:280:DyaL1c7psVamsg%3D%3D 2834036
11. R.M. Eisele G. Schumacher P. Neuhaus 2008 Local recurrence following hepatic radiofrequency ablation. Diagnosis and treatment Strahlenther Onkol 184 598 604 10.1007/s00066-008-1885-4 19016019
12. D. Georg P. Georg M. Hillbrand, et al. 2008 Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques Strahlenther Onkol 184 586 591 10.1007/s00066-008-1872-9 19016017
13. M. Hata K. Tokuuye S. Sugahara, et al. 2005 Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus Cancer 104 794 801 10.1002/cncr.21237 15981284 (Pubitemid 41113680)
14. M. Hata K. Tokuuye S. Sugahara, et al. 2007 Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites. Technical considerations and results Strahlenther Onkol 183 411 416 10.1007/s00066-007-1640-2 17680219 (Pubitemid 47230515)
15. H. Horigome T. Nomura H. Nakao, et al. 2000 Treatment of solitary small hepatocellular carcinoma: consideration of hepatic functional reserve and mode of recurrence Hepatogastroenterology 47 507 511 1:STN:280:DC%2BD3c3ltFyiuw%3D%3D 10791223
16. W.C. Hsu S.C. Chan L.L. Ting, et al. 2006 Results of three-dimensional conformal radiotherapy and thalidomide for advanced hepatocellular carcinoma Jpn J Clin Oncol 36 93 99 10.1093/jjco/hyi242 16517834
17. I. Ikai Y. Yamaoka Y. Yamamoto, et al. 1998 Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy Ann Surg 227 433 439 10.1097/00000658-199803000- 00016 1:STN:280:DyaK1c7os1aqtA%3D%3D 9527067 (Pubitemid 28131025)
18. T. Inada Y. Hayakawa K. Ohara, et al. 1983 Treatment planning system for high energy proton beam Nippon Acta Radiol 43 781 793 1:STN:280: DyaL2c%2FktFCntQ%3D%3D 6314247
19. S. Ishikura T. Ogino J. Furuse, et al. 2002 Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus Am J Clin Oncol 25 189 193 10.1097/00000421-200204000-00019 11943901 (Pubitemid 34293077)
20. T. Itamoto H. Nakahara H. Tashiro, et al. 2002 Hepatic arterial infusion of 5-fluorouracil and cisplatin for unresectable or recurrent hepatocellular carcinoma with tumor thrombus of the portal vein J Surg Oncol 80 143 148 10.1002/jso.10116 1:CAS:528:DC%2BD38XlvFKktrY%3D 12115797 (Pubitemid 34747619)
21. E.L. Kaplan P. Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
22. K. Kumada K. Ozawa R. Okamoto, et al. 1990 Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumor thrombi Surgery 108 821 827 1:STN:280:DyaK3M%2FkvVCjsQ%3D%3D 2173162
23. H.S. Lee J.S. Kin I.J. Choi, et al. 1997 The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study Cancer 79 2087 2094 10.1002/(SICI)1097-0142(19970601)79: 11<2087::AID-CNCR5>3.0.CO;2-M 1:STN:280:DyaK2szit1Gltg%3D%3D 9179054 (Pubitemid 27227372)
24. K. Lewin R.R. Millis 1973 Human radiation hepatitis. A morphologic study with emphasis on the late changes Arch Pathol 96 21 26 1:STN:280: DyaE3s7oslSgtg%3D%3D 4708001
25. J.M. Llovet A. Burroughs I. Bruix 2005 Updated treatment approach to hepatocellular carcinoma J Gastroenterol 40 225 235 10.1007/s00535-005-1566-3 15830281 (Pubitemid 40613379)
26. J.M. Llovet J. Bustamante A. Castells, et al. 1999 Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for design and evaluation of therapeutic trials Hepatology 29 62 67 10.1002/hep.510290145 1:STN:280:DyaK1M%2FotFKrsw%3D%3D 9862851 (Pubitemid 29023987)
27. K.A. McGlynn W.T. London 2005 Epidemiology and natural history of hepatocellular carcinoma Best Pract Res Clin Gastroenterol 19 3 23 10.1016/j.bpg.2004.10.004 15757802 (Pubitemid 40331495)
28. A.B. Miller B. Hoogstraten M. Staquet, et al. 1981 Reporting results of cancer treatment Cancer 47 207 214 10.1002/1097-0142(19810101)47:1<207::AID- CNCR2820470134>3.0.CO;2-6 1:STN:280:DyaL3M7htFOltw%3D%3D 7459811 (Pubitemid 11167383)
29. K. Nakagawa H. Yamashita K. Shiraishi, et al. 2005 Radiation therapy for portal venous invasion by hepatocellular carcinoma World J Gastroenterol 11 7237 7241 16437621
30. S. Obi H. Yoshida R. Toune, et al. 2006 Combination therapy of intra-arterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion Cancer 106 1990 1997 10.1002/cncr.21832 1:CAS:528:DC%2BD28XkvFGhs7s%3D 16565970 (Pubitemid 43673215)
31. K. Okuda T. Ohtsuki H. Obata, et al. 1985 Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 918 928 10.1002/1097-0142(19850815)56:4<918::AID- CNCR2820560437>3.0.CO;2-E 1:STN:280:DyaL2M3lsVaqtw%3D%3D 2990661 (Pubitemid 15228292)
32. H. Ota H. Nagano M. Sakon, et al. 2005 Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression Br J Cancer 93 557 564 10.1038/sj.bjc.6602742 1:CAS:528:DC%2BD2MXpsFalurg%3D 16106266 (Pubitemid 43079999)
33. A. Pawarode N. Voravud V. Sriuranpong, et al. 1998 Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients Am J Clin Oncol 21 386 391 10.1097/00000421-199808000-00014 1:STN:280:DyaK1cznt1entg%3D%3D 9708639 (Pubitemid 28366909)
34. M. Pech G. Wieners R. Kryza, et al. 2008 CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases. An intraindividual matched-pair analysis Strahlenther Onkol 184 302 306 10.1007/s00066-008-1815-5 18535805 (Pubitemid 351806518)
35. R.N. Pugh I.M. Murray-Lyon J.L. Dawson, et al. 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 649 10.1002/bjs.1800600817 1:STN:280:DyaE3s3jsVWqsw%3D%3D 4541913
36. The Research Group for Population-Based Cancer Registration in Japan in 1995. 2000 Estimates based on data from nine population-based cancer registries Jpn J Clin Oncol 30 318 321 10.1093/jjco/hyd081
37. Sobin LH, Wittekind C, eds. TNM classification of malignant tumours, 6th edn. New York: Wiley & Sons, 2002.
38. N. Tanaka Y. Matsuzaki Y. Chugangi, et al. 1992 Proton irradiation for hepatocellular carcinoma Lancet 340 1358 10.1016/0140-6736(92)92546-R 1:STN:280:DyaK3s%2FnvVGisQ%3D%3D 1360077
39. B. Timmermann A.J. Lomax L. Nobile, et al. 2007 Novel technique of craniospinal axis proton therapy with the spot-scanning system. Avoidance of patching multiple fields and optimized ventral dose distribution Strahlenther Onkol 183 685 688 10.1007/s00066-007-1759-1 18040613 (Pubitemid 350175413)
40. E. Villa A. Moles I. Ferretti, et al. 2000 Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival Hepatology 32 233 238 10.1053/jhep.2000.9603 1:CAS:528:DC%2BD3cXlvVyjtrY%3D 10915729
41. C. Wang H. Nakayama S. Sugahara, et al. 2009 Comparisons of dose-volume histograms for proton-beam versus 3-D conformal X-ray therapy in patients with stage I non-small cell lung cancer Strahlenther Onkol 185 231 234 10.1007/s00066-009-1923-x 19370425
42. J.T. Wharton L. Delclos S. Gallager, et al. 1973 Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique Am J Roentgenol Radium Ther Nucl Med 117 73 80 1:STN:280:DyaE3s%2FptFGhtQ%3D%3D 4685535
43. A. Yamada M. Sato M. Kawabata, et al. 1983 Hepatic artery embolisation in 120 patients with unresectable hepatoma Radiology 148 397 401 1:STN:280:DyaL3s3kvVWhsA%3D%3D 6306721
44. A.S. Yu E.B. Keeffe 2003 Management of hepatocellular carcinoma Rev Gastroenterol Disord 3 8 24 1:CAS:528:DC%2BD3sXps1Cqt7w%3D 12684589
45. Z.C. Zeng J. Fan Z.Y. Tang, et al. 2005 A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus Int J Radiat Oncol Biol Phys 61 432 443 15667964